Yeluri Formulations Private Limited

Yeluri Formulations Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24230TG1997PTC026188 Incorporated 15 January 1997 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2025
₹96.05 Cr
▼ 23% YoY
Net profit · FY 2025
₹65.56 Lakh
Net margin 0.7%
EBITDA · FY 2025
₹4.27 Cr
EBITDA margin 4.4%
Authorised capital
₹3.15 Cr
Registered with MCA
Paid-up capital
₹2.33 Cr
Issued & subscribed
Open charges
₹57.33 Cr
Satisfied ₹40.78 Cr
Company age
29 yrs
Est. 1997
Employees · EPFO
69
Provident fund records

About Yeluri Formulations Private Limited

Data last updated:

Yeluri Formulations Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 January 1997 and has been in existence for over 29 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG1997PTC026188. Its GSTIN is 36AAACY1267G1ZC (Telangana). The company holds 3 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹3.15 Cr and a paid-up capital of ₹2.33 Cr. It is led by directors including Yeluri Hari Prasad (Managing Director) and Eluri Nageswara Rao.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 3rd Floor A.V.M. Towers Beside Siva Parvathi Theatre Opp: Kphb Kukatpally, Hyderabad, Telangana, India – 500072.

As per the financials filed for FY 2025, the company reported a revenue of ₹96.05 Cr, a decline of 23% compared to the previous year. For the same year it recorded a net profit of ₹65.56 Lakh (net margin 0.7%) and EBITDA of ₹4.27 Cr (EBITDA margin 4.4%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 2% over five years.

The company has about 69 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Yeluri. As per MCA filings, the company has open charges of ₹57.33 Cr and satisfied charges of ₹40.78 Cr on record. Court records list 17 cases involving the company, including 5 filed by the company and 12 filed against it; 4 cases are pending. The company has 9 deals on record (8 secondary share transfers, 1 funding round), with disclosed funding of ₹1.05 Cr; the latest was in August 2022. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Veer Chemie and Aromatics Pvt Ltd with revenue of ₹97.47 Cr.

Yeluri Formulations Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0004299). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website yeluri.net.

Company details

CIN U24230TG1997PTC026188
Registration Number 026188
Incorporation Date 15 January 1997
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0004299

CIN history

Yeluri Formulations has one previous CIN (Corporate Identification Number): U24230AP1997PTC026188. The current CIN is U24230TG1997PTC026188, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24230TG1997PTC026188Current
U24230AP1997PTC026188Previous

Recognitions & Rankings of Yeluri Formulations

MSME (Udyam registered) Ministry of MSME
Category
Small (2022-23)
Udyam number
UDYAM-TS-20-0004299

Contact details

Yeluri Formulations Private Limited's registered office is in Hyderabad, Telangana. Its website is yeluri.net. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
  • Registered Address
    3rd Floor A.V.M. Towers Beside Siva Parvathi Theatre Opp: Kphb Kukatpally, Hyderabad, Telangana, India – 500072
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Yeluri Formulations Private Limited, buy the company report.

Comprehensive company report
Yeluri Formulations Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Yeluri Formulations operates one associated brand: Yeluri. Each brand links to its own profile.

BrandDescriptionWebsite
Manufactures traditional pharmaceutical formulations for the healthcare industry.yeluri.net

Business activity

The main business activity of Yeluri Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Yeluri Formulations Private Limited, buy the company report.

Financials of Yeluri Formulations Private Limited

FY 2024 filings available

Yeluri Formulations Private Limited reported revenue of ₹96.05 Cr (down 23% YoY) for FY 2025.

Revenue · FY 2025
₹96.05 Cr ▼ 23%
Net profit · FY 2025
₹65.56 Lakh margin 0.7%
EBITDA · FY 2025
₹4.27 Cr margin 4.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 23%
3 years · compounded
▲ 7%
5 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▼ 9%
3 years · compounded
▲ 4%
5 years · compounded
▼ 1%

Revenue fell 23% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA fell 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹4.27 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹65.56 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin4.4%
Net Profit Margin0.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Yeluri Formulations Private Limited, buy the company report.

Board of directors of Yeluri Formulations Private Limited

Yeluri Formulations has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Manogna YeluriAdditional Director28 Jun 20215 Years 4 MonthsCurrent
Eluri Nageswara RaoDirector01 Apr 200917 Years 7 MonthsCurrent
Eluri SrideviDirector01 Apr 200917 Years 7 MonthsCurrent
Yeluri Hari PrasadManaging Director01 Apr 200917 Years 7 MonthsCurrent

Peer comparison

Yeluri Formulations Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Veer Chemie and Aromatics Pvt Ltd₹97.47 Cr (FY 2024)11.0%Telangana, India
Pharma Chem Industries (Gujarat) Private Limited₹97.24 Cr (FY 2025)20.0%Vapi, Gujarat, India
V S International Private Limited₹96.26 Cr (FY 2024)65.0%Mumbai, Maharashtra, India
XL Laboratories Private Limited₹96.06 Cr (FY 2025)17.0%New Delhi, Delhi, India
Yeluri Formulations Private Limitedthis company₹96.05 Cr (FY 2025)₹65.56 Lakh0.7%-23.0%69Hyderabad, Telangana, India
MCW Healthcare Private Limited₹95.35 Cr (FY 2024)16.0%Madhya Pradesh, India
Surmount Laboratories Limited₹95.33 Cr (FY 2024)-6.0%Mumbai, Maharashtra, India
Ang Lifesciences India Limited₹94.87 Cr (FY 2025)-35.0%Amritsar, Punjab, India
Bio-Med Private Limited₹94.67 Cr (FY 2025)19.0%Uttar Pradesh, India

To see the full peer comparison of Yeluri Formulations Private Limited, buy the company report.

Auditor

Yeluri Formulations Private Limited is audited by B NARSING RAO & CO LLP for the financial year 2024.

Auditor firmFinancial yearFirm registration number
B NARSING RAO & CO LLPFY 2024002409S

Shareholding

The shareholding of Yeluri Formulations Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Yeluri Formulations Private Limited, buy the company report.

Charges & borrowings

Open charges
₹57.33 Cr
Satisfied charges
₹40.78 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹44.81 Cr
Others₹10.57 Cr
Sidbi₹1.94 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
29 Sep 2025101161579Sidbi₹1.94 CrOpen
30 Jun 2025101118189Others₹2.57 CrOpen
16 Oct 2024100987382Others₹8 CrOpen
18 Apr 2023100711611Hdfc Bank Limited₹22.08 LakhOpen
25 Feb 2020100389471Hdfc Bank Limited₹44.59 CrOpen

To see the full charge records of Yeluri Formulations Private Limited, buy the company report.

Total charge records: 16 View all charges

Deals & funding

Yeluri Formulations Private Limited has 9 deals on record (8 secondary share transfers, 1 funding round), with disclosed funding of ₹1.05 Cr; the latest was in August 2022.

Total deals
9
Secondary share transfers
8
Funding round
1
Disclosed funding
₹1.05 Cr

Deals on record (5 of 9)

WhenDealAmountParties
Aug 2022Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Jan 2022Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Jul 2021Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Jun 2021Secondary share transferUndisclosedBuyer: 2 individuals
Seller: 2 individuals
Jun 2021Secondary share transferUndisclosedBuyer: an individual
Seller: an individual

To see the full deal history of Yeluri Formulations Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Yeluri Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Yeluri Formulations Private Limited has a workforce of 69 employees on its EPFO records as of Mar 2026, across 1 active EPFO establishment.

Employee count
69
Active EPFO establishments
1
Employee growth
35.3%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2025-2669
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Yeluri Formulations Private Limited, buy the company report.

GST

Yeluri Formulations has 3 GST registrations: 1 active and 2 cancelled or inactive.

Total GSTINs
3
Active
1
Cancelled / inactive
2
GSTINStateStatusRegistered on
36AAACY1267G1ZCTelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Yeluri Formulations Private Limited, buy the company report.

Recent activity

Yeluri Formulations Private Limited has 8 board changes on record since 2009: 4 appointments and 4 cessations. The latest: Surya Prakasa Rao Yeluri ceased to be Managing Director on 04 Aug 2022.

Charges
A charge with Sidbi amounted to Rs. 1.94 Cr with Charge ID 101161579 was registered on 29 Sep 2025.
Charges
A charge with Others amounted to Rs. 2.57 Cr with Charge ID 101118189 was registered on 30 Jun 2025.
Charges
A charge with Others of Rs. 8.00 Cr registered on 16 Oct 2024 with Charge ID 100987382 was modified on 26 Jun 2025.
Charges
A charge with Hdfc Bank Limited of Rs. 44.59 Cr registered on 25 Feb 2020 with Charge ID 100389471 was modified on 19 Feb 2025.
Charges
A charge with Others amounted to Rs. 8.00 Cr with Charge ID 100987382 was registered on 16 Oct 2024.
AGM
Yeluri Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Yeluri Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.22 Cr with Charge ID 100711611 was registered on 18 Apr 2023.
Ceased
Surya Prakasa Rao Yeluri ceased to be Managing Director.
Ceased
Yeluri Hari Prasad ceased to be Director.
Appointed
Manogna Yeluri was appointed as Additional Director.
Charges
A charge registered on 20 Jul 2012 via Charge ID 10365772 with Ing Vysya Bank Limited was fully satisfied on 01 Apr 2021.

30 earlier events are in the company report.

Frequently asked questions

Yeluri Formulations is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 January 1997 (29+ years old) and is registered under CIN U24230TG1997PTC026188.

Yeluri Formulations has 4 current directors:

The latest financial statements of Yeluri Formulations on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Yeluri Formulations is 36AAACY1267G1ZC, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.

The CIN (Corporate Identification Number) of Yeluri Formulations is U24230TG1997PTC026188. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yeluri Formulations has 17 court cases on record: 5 filed by the company and 12 filed against it. 4 are pending. Most are in the district courts.

Yeluri Formulations was incorporated on 15 January 1997, making it 29+ years old. It is registered with the Registrar of Companies, Hyderabad.

Yeluri Formulations has 9 deals on record (8 secondary share transfers, 1 funding round), with disclosed funding of ₹1.05 Cr; the latest was in August 2022.

The peers of Yeluri Formulations by revenue are Veer Chemie and Aromatics Pvt Ltd, Pharma Chem Industries (Gujarat) Private Limited, V S International Private Limited, XL Laboratories Private Limited, MCW Healthcare Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Surya Prakasa Rao Yeluri ceased to be Managing Director on 04 Aug 2022. Yeluri Hari Prasad ceased to be Director on 04 Aug 2022. Manogna Yeluri was appointed as Additional Director on 28 Jun 2021. Yeluri Formulations has 8 board changes on record in total.

Yes, Yeluri Formulations is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0004299).